As part of a cooperative agreement with the City Council, Añatuya will be subject to an second round of intensive fumigation in order to control the proliferation of this dangerous vector.

An important staff member of the World Health Organisation (WHO) has warned about a drastic reduction in the global availability of yellow fever vaccines

Funded by ELEA Laboratories and Hugo Sigman, Argentine scientists have recently developed a new vaccine that could be effective in the treatment of lung tumours. Based on the promising results obtained during the initial stages of development, the vaccine is now expected to be tested in advanced clinical trials before its final approval by local health authorities.

The subtropical areas near the borders between Argentina, Brazil and Paraguay have recently witnessed an important increase in the number of yellow fever cases. We hereby provide some useful information regarding transmission, symptoms, treatments and prevention of this dangerous disease.

A study on resistance to chemical control tools of Chagas prevention campaigns has started. Based on the analysis of genetic mutations in "vinchucas", the researh by Sheila Ons seeks to generate a test for the early detection of resistance.

In 2008 Mundo Sano headquarters in Puerto Iguazú will start working on a new research project on malaria.

Mundo Sano participates in the 2nd Regional Symposium on Cooperation in Tele-Epidemiology, organized by the National Commission on Space Activities (Spanish acronym: CONAE).

On October 9 and 10, there was a workshop jointly organized by Mundo Sano, PAHO and the WHO's Special Program on Tropical Diseases Research and Training (TDR).

Mundo Sano is an active partner of the commission for vector control.